Notas del episodio
This week, we dissect the seismic news from Brazil. ANVISA just launched an accelerated approval pathway for AI-powered medical devices, creating a potential gold rush for MedTech innovators. This episode explores the immense opportunity for rapid market entry and the critical, hidden compliance challenges that come with it.
We uncover the stringent new post-market surveillance and data reporting requirements that could trap unprepared manufacturers. Imagine securing a landmark approval for your diagnostic software in record time, only to face the risk of market withdrawal due to unforeseen…
Web: pureglobal.com

